1. Home
  2. ELOX vs INCR Comparison

ELOX vs INCR Comparison

Compare ELOX & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$13.20

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Logo Intercure Ltd.

INCR

Intercure Ltd.

N/A

Current Price

$4.51

Market Cap

58.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELOX
INCR
Founded
1999
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
58.6M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ELOX
INCR
Price
$13.20
$4.51
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $38.25
N/A
AVG Volume (30 Days)
★ 17.7K
3.3K
Earning Date
08-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 41.67
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$203.61
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$10.00
$0.68
52 Week High
$23.40
$6.10

Technical Indicators

Market Signals
Indicator
ELOX
INCR
Relative Strength Index (RSI) 40.05 41.79
Support Level $10.74 $0.81
Resistance Level $14.65 $5.58
Average True Range (ATR) 1.28 0.22
MACD -0.04 -0.11
Stochastic Oscillator 21.89 11.43

Price Performance

Historical Comparison
ELOX
INCR

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: